RUS
Details
| Name | Veropharm |
| Placement specification | common stock |
| Placement type | IPO |
| Subscription type | Private placement |
| Start of placement | 11.04.2006 |
| Status | Completed |
| End of placement | 25.04.2006 |
| Placement amount | 4 990 000 |
| Placement volume, mln. USD | 140 |
| Upper bound, USD | 29.00 |
| Lower bound, USD | 24.00 |
| Offering price, USD | 28.00 |
| Price change from the placement date | -11.79% |
| Trading floor | RTS |
| Investment banks | Troika Dialog |
| Capitalisation at the moment of placement, mln. USD | 280 |
| Country of operation | Russia |
| Industry | Pharmaceutical industry |
Issuer
Veropharm is one of the LEADING GENERIC PHARMACEUTICAL MANUFACTURERS in Russia, active across major pharmaceutical areas, with leading market positions in oncology drugs and adhesive bandages.
Veropharm has THREE MAIN PRODUCTION FACILITIES — located in the cities of Voronezh, Belgorod and in the Vladimir region (Pokrov).
Veropharm has THREE MAIN PRODUCTION FACILITIES — located in the cities of Voronezh, Belgorod and in the Vladimir region (Pokrov).
Web-site: to the issuer site
Issuer news
-
16.12.2010
Investfunds: RMG Research: Veropharm: Strong Upside as Receivables Come Down
-
07.12.2009
Investfunds: RMG Research: Pharmaceutical Producers: Veropharm Risks are Exaggerated
Stock details
| Stock | Veropharm |
| Type | common stock |
| Par value, RUB | 1 |
| State registration number | 1-02-00575-H |
| ISIN | RU000A0JL475 |
| Announced volume | 10 000 000 |
| Free-float | 0.48 |
MICEX
Ticker:
VFRM
Quotation list:
Unlisted stocks
RTS
Ticker:
VRPH
Quotation list:
B
Price dynamics
| MICEX | RTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||